Organ Impairment—Drug–Drug Interaction Database: A Tool for Evaluating the Impact of Renal or Hepatic Impairment and Pharmacologic Inhibition on the Systemic Exposure of Drugs

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|4|8|489-494

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.4, Iss.8, 2015-08, pp. : 489-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of Fetal and Neonatal Renal Impairment by Pharmacologic Inhibition of Angiotensin

By  

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4572-4580

Bentham Science Publishers

Access to resources Recommend Favorite

Drug dosage in renal impairment: variation in recommendations

By  

Inpharma, Vol. 1, Iss. 1490, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Potential Drug Targets and Progress Towards Pharmacologic Inhibition of Hepatic Glucose Production

By  

Current Medicinal Chemistry, Vol. 10, Iss. 2, 2003-01 ,pp. : 123-153

Bentham Science Publishers

Access to resources Recommend Favorite

Cisplatin/various drugs interaction: Renal impairment: case report

By  

Reactions Weekly, Vol. 1, Iss. 1283, 2010-01 ,pp. : 31-32

Adis International

Access to resources Recommend Favorite

Asenapine Pharmacokinetics in Hepatic and Renal Impairment

By Peeters Pierre  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 471-481

Adis International

Access to resources Recommend Favorite